B cells sustain tumor-specific CD4 T cells to promote response to PD-1 targeted therapy
Abishek Balachandra Vaidya, Étienne Humblin, Nataliya Prokhnevska, Verena van der Heide, Laurine Binet, Jachym Harwood, Raphaël Mattiuz, Anthony Lozano, Pauline Hamon, Bruno Cogliati, Simon Goldstein, Isabel Korpas, Katherine E. Lindblad, Suhaana Sriram, Harald Hartweger, , Alice Oliffson Kamphorst
This study shows that B cells support tumor-specific CD4 T cells to enhance PD-1 blockade efficacy, but antibody secretion is not necessary for long-term survival.
bioRxiv · Sep 24, 2026 · PreprintImmunology